Method of treatment of melanoma with alpha thymosin peptide combined with antibody against cytotoxic T lymphocyte antigen 4 (CTLA4)

摘要

Melanoma or a metastasis thereof is treated in a human patient in a combination therapy which includes administering a melanoma-treating combination to a human melanoma patient during a treatment regimen, the combination including an alpha thymosin peptide and antibodies against cytotoxic T lymphocyte-associated antigen 4 (CTLA4).